Lung Cancer Symptom Assessment and Management Intervention
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 179
- 试验地点
- 2
- 主要终点
- % completion of intervention use and adherence to suggested symptom management strategies.
研究概览
简要总结
The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years.
- •Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the out-patient setting; receiving treatment with chemotherapy +/- additional therapies; English speaking.
排除标准
- •Patients: Any patient who needs emergent care, routine visits scheduled less than once a month
研究组 & 干预措施
SAMI
Patients and Health care providers use Symptom Assessment and Management Intervention: patient report symptoms by answering validated questionnaires in a secure online program. The system generates a report for providers that displays symptoms and customized suggestions for their clinical management.
干预措施: SAMI (Behavioral)
Usual Care
Symptom assessment and management follows customary procedures in each study site.
结局指标
主要结局
% completion of intervention use and adherence to suggested symptom management strategies.
时间窗: 2 years
次要结局
- Health-related quality of life(6 months)
研究者
Mary E. Cooley, Phd
Nurse Scientist
Dana-Farber Cancer Institute